Home/Filings/4/0001127602-25-008726
4//SEC Filing

Clark James David 4

Accession 0001127602-25-008726

CIK 0000064803other

Filed

Mar 6, 7:00 PM ET

Accepted

Mar 7, 4:56 PM ET

Size

8.2 KB

Accession

0001127602-25-008726

Insider Transaction Report

Form 4
Period: 2025-03-05
Clark James David
SVP, Cont & Chief Acct Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2025-03-05$62.21/sh+7,513$467,38415,907 total
  • Exercise/Conversion

    Stock Option

    2025-03-057,5130 total
    Exercise: $62.21From: 2019-04-01Exp: 2025-04-01Common Stock (7,513 underlying)
  • Sale

    Common Stock

    2025-03-05$66.35/sh7,513$498,4888,394 total
Footnotes (1)
  • [F1]Options became exercisable in four equal annual installments, commencing 4/1/2019.

Issuer

CVS HEALTH Corp

CIK 0000064803

Entity typeother

Related Parties

1
  • filerCIK 0001757584

Filing Metadata

Form type
4
Filed
Mar 6, 7:00 PM ET
Accepted
Mar 7, 4:56 PM ET
Size
8.2 KB